Stocks Overview

LAST PRICE
31.5600
TODAY'S CHANGE (%)
Trending Down-1.1100 (-3.3976%)

Bid / Lots
28.3200/ 1
Ask / Lots
32.9200/ 1
Open / Previous Close
32.6700 / 32.6700
Day Range
Low 31.5200
High 32.9300
52 Week Range
Low 20.8400
High 35.2200
Volume
977,713
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Monday's close: 32.67
Time	Volume	CORT
09:32 ET	9847	32.64
09:36 ET	100	32.6
09:38 ET	100	32.56
09:39 ET	400	32.7
09:41 ET	210	32.7
09:45 ET	701	32.66
09:48 ET	3512	32.685
09:50 ET	2976	32.68
09:52 ET	400	32.685
09:54 ET	1250	32.8
09:56 ET	4901	32.66
09:57 ET	350	32.71
09:59 ET	500	32.75
10:01 ET	901	32.785
10:03 ET	8844	32.76
10:06 ET	200	32.69
10:08 ET	1683	32.73
10:10 ET	808	32.69
10:12 ET	900	32.715
10:14 ET	602	32.77
10:15 ET	11568	32.74
10:17 ET	200	32.75
10:19 ET	222	32.7649
10:21 ET	100	32.8
10:24 ET	24321	32.71
10:26 ET	17568	32.71
10:28 ET	1515	32.768
10:30 ET	200	32.87
10:32 ET	200	32.9029
10:33 ET	1083	32.82
10:35 ET	253	32.835
10:37 ET	300	32.87
10:39 ET	100	32.93
10:42 ET	1018	32.84
10:44 ET	500	32.78
10:46 ET	700	32.7
10:48 ET	519	32.65
10:50 ET	2550	32.7
10:51 ET	1373	32.66
10:53 ET	2284	32.6
10:55 ET	4285	32.58
10:57 ET	3950	32.55
11:00 ET	5721	32.45
11:02 ET	450	32.4
11:06 ET	1614	32.39
11:08 ET	100	32.4
11:09 ET	1663	32.41
11:11 ET	1462	32.405
11:13 ET	1139	32.39
11:15 ET	5487	32.47
11:20 ET	1672	32.445
11:22 ET	1200	32.47
11:26 ET	2120	32.5
11:27 ET	590	32.49
11:29 ET	300	32.53
11:31 ET	288	32.51
11:33 ET	543	32.535
11:36 ET	3266	32.465
11:38 ET	1050	32.41
11:40 ET	1034	32.3973
11:42 ET	1482	32.37
11:44 ET	250	32.36
11:45 ET	2120	32.45
11:47 ET	5639	32.34
11:49 ET	1573	32.32
11:51 ET	500	32.325
11:54 ET	1124	32.29
11:56 ET	3550	32.28
11:58 ET	4505	32.26
12:00 ET	600	32.24
12:02 ET	1825	32.18
12:03 ET	434	32.186
12:05 ET	686	32.175
12:07 ET	100	32.21
12:09 ET	4121	32.2
12:12 ET	1502	32.18
12:14 ET	600	32.18
12:16 ET	4629	32.05
12:18 ET	600	32.09
12:20 ET	1506	32.16
12:21 ET	200	32.155
12:23 ET	1491	32.15
12:25 ET	500	32.13
12:27 ET	511	32.12
12:32 ET	1699	32.11
12:34 ET	2239	32.14
12:36 ET	2964	32.09
12:38 ET	899	32.12
12:39 ET	615	32.1015
12:41 ET	1461	32.08
12:43 ET	2164	32.1
12:50 ET	636	32.1506
12:52 ET	100	32.15
12:54 ET	400	32.15
12:56 ET	3131	32.11
12:57 ET	1678	32.1
12:59 ET	2836	32.06
01:01 ET	5640	32
01:03 ET	2940	32.07
01:06 ET	2992	32.04
01:08 ET	3290	31.9701
01:10 ET	2071	32
01:12 ET	100	32.02
01:14 ET	255	32.02
01:15 ET	1000	32
01:17 ET	1879	31.99
01:19 ET	300	31.99
01:21 ET	100	31.98
01:24 ET	200	31.98
01:26 ET	200	31.98
01:28 ET	873	31.98
01:30 ET	300	31.98
01:32 ET	2496	31.9651
01:33 ET	767	31.94
01:35 ET	1501	31.955
01:37 ET	13460	31.995
01:39 ET	400	31.99
01:42 ET	1500	32.01
01:44 ET	1500	31.96
01:46 ET	1238	31.955
01:48 ET	3451	31.9719
01:50 ET	600	32.02
01:51 ET	200	31.98
01:53 ET	1067	31.97
01:55 ET	1453	31.97
01:57 ET	300	31.97
02:00 ET	7552	31.97
02:02 ET	2027	31.975
02:04 ET	300	31.9725
02:06 ET	1324	31.91
02:08 ET	400	31.91
02:09 ET	1903	31.98
02:11 ET	300	31.95
02:13 ET	1266	31.945
02:15 ET	500	31.93
02:18 ET	600	31.92
02:20 ET	307	31.95
02:22 ET	693	31.93
02:24 ET	3609	31.99
02:26 ET	1650	31.99
02:27 ET	500	32.04
02:29 ET	1802	32.03
02:31 ET	2868	32.07
02:36 ET	6972	32.01
02:38 ET	607	32.015
02:40 ET	200	32.01
02:42 ET	2665	31.99
02:44 ET	1616	31.98
02:45 ET	1000	31.96
02:47 ET	2197	31.98
02:49 ET	500	31.98
02:51 ET	737	31.985
02:54 ET	2000	32.05
02:56 ET	1460	32
02:58 ET	5154	31.985
03:00 ET	1241	31.97
03:02 ET	1000	31.95
03:03 ET	1400	31.95
03:05 ET	1000	31.92
03:07 ET	2151	31.93
03:09 ET	953	31.935
03:12 ET	200	31.92
03:14 ET	5380	31.93
03:16 ET	3305	31.91
03:18 ET	1300	31.98
03:20 ET	4509	31.97
03:21 ET	9361	31.93
03:23 ET	289	31.92
03:25 ET	851	31.89
03:27 ET	700	31.87
03:30 ET	2525	31.87
03:32 ET	3287	31.87
03:34 ET	2411	31.79
03:36 ET	5809	31.79
03:38 ET	5680	31.71
03:39 ET	6689	31.765
03:41 ET	1985	31.8
03:43 ET	5491	31.81
03:45 ET	1853	31.78
03:48 ET	6569	31.69
03:50 ET	6925	31.73
03:52 ET	4323	31.7601
03:54 ET	5367	31.75
03:56 ET	29598	31.56
03:57 ET	27389	31.6
03:59 ET	29766	31.56

Data delayed at least 15 minutes.

Yesterday
- DJ Corcept Therapeutics Price Target Maintained With a $35.00/Share by Piper Sandler, from 9:54AM ET on Monday Jul 01, 2024 by Dow Jones
  9:54AM ET on Monday Jul 01, 2024 by Dow Jones
Jun 24, 2024
- Corcept Announces Presentation of Results From Prevalence Phase of CATALYST Clinical Trial at American Diabetes Association's Scientific Sessions, from 4:15PM ET on Monday Jun 24, 2024 by Dow Jones
  4:15PM ET on Monday Jun 24, 2024 by Dow Jones
Jun 17, 2024
- DJ Corcept Therapeutics Is Maintained at Buy by Truist Securities, from 11:37AM ET on Monday Jun 17, 2024 by Dow Jones
  11:37AM ET on Monday Jun 17, 2024 by Dow Jones
Jun 4, 2024
- DJ Corcept Therapeutics Price Target Raised to $65.00/Share From $44.00 by Truist Securities, from 9:32AM ET on Tuesday Jun 04, 2024 by Dow Jones
  9:32AM ET on Tuesday Jun 04, 2024 by Dow Jones
Jun 3, 2024
- Corcept Therapeutics Announces Presentations of Results of Pivotal Phase 3 GRACE Trial Evaluating Relacorilant in Patients with Hypercortisolism (Cushing's Syndrome), from 8:00AM ET on Monday Jun 03, 2024 by Dow Jones
  8:00AM ET on Monday Jun 03, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesCORT Corcept Therapeutics Inc	3.4B	29.5x	+9.80%
United StatesANIP ANI Pharmaceuticals Inc	1.3B	39.3x	-8.16%
United StatesHRMY Harmony Biosciences Holdings Inc	1.7B	13.0x	---
United StatesHCM HUTCHMED (China) Ltd	3.1B	30.0x	---
United StatesAMPH Amphastar Pharmaceuticals Inc	1.9B	13.0x	---
United StatesCOLL Collegium Pharmaceutical Inc	1.1B	15.6x	---
As of 2024-07-02

Corcept Therapeutics Incorporated is a commercial-stage company, which is engaged in the discovery and development of medications to treat severe endocrine, oncologic, metabolic and neurological disorders by modulating the effects of the hormone cortisol. The Company operates through the discovery, development and commercialization of the pharmaceutical products segment. The Company has marketed Korlym (mifepristone) in the United States for the treatment of patients suffering from Cushings syndrome. The Company’s portfolio of selective cortisol modulators consists of four series totaling approximately 1,000 compounds. Its portfolio of selective cortisol modulators consists of relacorilant, exicorilant, dazucorilant and miricorilant. Korlyms active ingredient, mifepristone, reduces the binding of excess cortisol to the GR, it can modulate the effects of abnormal levels and release patterns of cortisol without compromising cortisols healthy functions and rhythms.

Contact Information

Headquarters: 149 Commonwealth DrMENLO PARK, CA, United States 94025
Phone: 650-688-8803
Fax: 650-327-3218

Executives

Independent Chairman of the Board: James Wilson
President, Chief Executive Officer, Co-Founder, Director: Joseph Belanoff
Chief Financial Officer, Treasurer: Atabak Mokari
President - Corcept Endocrinology: Sean Maduck
President - Oncology: Roberto Vieira

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$3.4B
Revenue (TTM)	$523.5M
Shares Outstanding	104.1M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.44
EPS	$1.07
Book Value	$4.90
P/E Ratio	29.5x
Price/Sales (TTM)	6.5
Price/Cash Flow (TTM)	28.6x
Operating Margin	23.29%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Corcept Therapeutics Inc
NASDAQ:CORTUnited States

Search Criteria

Charts

Recent News

Yesterday

DJ Corcept Therapeutics Price Target Maintained With a $35.00/Share by Piper Sandler, from 9:54AM ET on Monday Jul 01, 2024 by Dow Jones

Jun 24, 2024

Corcept Announces Presentation of Results From Prevalence Phase of CATALYST Clinical Trial at American Diabetes Association's Scientific Sessions, from 4:15PM ET on Monday Jun 24, 2024 by Dow Jones

Jun 17, 2024

DJ Corcept Therapeutics Is Maintained at Buy by Truist Securities, from 11:37AM ET on Monday Jun 17, 2024 by Dow Jones

Jun 4, 2024

DJ Corcept Therapeutics Price Target Raised to $65.00/Share From $44.00 by Truist Securities, from 9:32AM ET on Tuesday Jun 04, 2024 by Dow Jones

Jun 3, 2024

Corcept Therapeutics Announces Presentations of Results of Pivotal Phase 3 GRACE Trial Evaluating Relacorilant in Patients with Hypercortisolism (Cushing's Syndrome), from 8:00AM ET on Monday Jun 03, 2024 by Dow Jones

Pharmaceuticals - Diversified Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar